Log in to save to my catalogue

Botulinum toxin in patients with multiple sclerosis

Botulinum toxin in patients with multiple sclerosis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_754557501

Botulinum toxin in patients with multiple sclerosis

About this item

Full title

Botulinum toxin in patients with multiple sclerosis

Publisher

Germany

Journal title

Journal of neurology, 2006-02, Vol.253 Suppl 1 (S1), p.I26-i28

Language

English

Formats

Publication information

Publisher

Germany

More information

Scope and Contents

Contents

Nearly all patients with multiple sclerosis (MS) will develop spasticity in the course of their disease. This symptom accounts for most of the handicap and impairment in the quality of life. Treatment with botulinum toxin will enable an efficient and safe alleviation of spasticity and the problems involved, given a realistic definition of the thera...

Alternative Titles

Full title

Botulinum toxin in patients with multiple sclerosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_754557501

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_754557501

Other Identifiers

ISSN

0340-5354

E-ISSN

1432-1459

DOI

10.1007/s00415-006-1106-y

How to access this item